CobiCure

What CobiCure does

CobiCure is a 501c3 public charity and pediatric MedTech accelerator operating within the Advancium Health Network, founded in June 2022 by Deerfield Management and Deerfield Foundation. The organization addresses structural barriers in pediatric medical device development — small market sizes, ROI disincentives (cited by 76% of pediatric MedTech KOLs), fragmented stakeholders, and 63% off-label device use in pediatric interventional cardiology — by providing non-dilutive grants, fellowship training, and ecosystem convening to innovators developing devices and therapeutics for children, particularly those with rare diseases and congenital heart conditions.

CobiCure's core offerings are programmatic rather than product-based: (1) a grant program that has deployed at least $2M to PolyVascular for a pediatric heart valve; (2) the CobiCure Fellowship for Pediatric MedTech Innovation, launched in September 2024 with all five FDA Pediatric Device Consortia (Midwest PDC, Southwest-Midwest, UCSF-Stanford, Alliance for Pediatric Device Innovation, CTIP) and Stanford Biodesign, training 5 fellows in the 2024-2025 cohort; (3) the Maxine and Stuart Frankel Accelerator, a $10M program established July 2025 for pediatric clinical development; (4) the annual Pediatric MedTech CEO Summit; and (5) participation in the FNIH-led SHIP-MD public-private partnership for clinical evidence generation. Communit y events (Impact Series, PICS Shark Tank) and digital channels (podcast, webinars on in silico trials with Virtonomy) extend the platform.

The business model is philanthropic and non-commercial: CobiCure does not charge for services and is funded by foundation grants (cumulative ~$40M from the Maxine and Stuart Frankel Foundation alone) and donor capital, prioritizing healthcare impact over financial returns. Its GTM motion is community-led and event-driven — convening clinicians, investors, regulators, and innovators rather than selling a product. Leverage from Deerfield Management's healthcare investment ecosystem provides differentiated deal flow and scientific expertise that most nonprofit accelerators cannot match.

Name

CobiCure

Legal name

CobiCure, LLC

Website

https://cobicuremedtech.org

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

CobiCure is a 501c3 pediatric MedTech accelerator within Advancium Health Network that provides non-dilutive grants, fellowships, and ecosystem convening to clinicians, researchers, and startups developing medical devices and therapeutics for children with rare diseases and congenital heart conditions.

Ownership category

akta.pro rank

Product category

Pediatric Medical Device Innovation Acceleration

NAICS

Educational Support Services (61171), Professional Organizations (81392)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Early Childhood Education & Childcare Nonprofits (BPAGADAA)

akta.pro secondary industry

Pediatric Rehabilitation & Developmental Therapy Centers (PT/OT/SLP) (HLAFAJAL)

Keywords

• Pediatric medical devices
• Nonprofit MedTech accelerator
• Innovation grants
• Pediatric fellowship program
• Rare disease therapeutics

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales

Revenue model

1. Philanthropic Grants and Donations: CobiCure is a 501c3 public charity that operates through philanthropic capital from foundations and donors. They provide non-dilutive funding, grants, and investments to pediatric MedTech innovators, prioritizing healthcare impact over financial returns.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

CobiCure is a 501(c)(3) nonprofit accelerator that advances pediatric medical device and therapeutic innovation through non-dilutive grant funding, fellowship training, and ecosystem convening. It channels philanthropic capital from foundations such as the Maxine and Stuart Frankel Foundation to selected pediatric MedTech companies and innovators, while operating programs like the CobiCure Fellowship for Pediatric MedTech Innovation, the Maxine and Stuart Frankel Accelerator, and the annual Pediatric MedTech CEO Summit.

Product overview

CobiCure is a nonprofit company within the Advancium Health Network that operates as a pediatric-focused health innovation accelerator, not a single product company. Its offerings consist of grant programs providing funding to pediatric MedTech innovators (including a $2M grant to PolyVascular for pediatric heart valves), the CobiCure Fellowship for Pediatric MedTech Innovation (in partnership with five FDA Pediatric Device Consortia), the Maxine and Stuart Frankel Accelerator ($10M program for pediatric clinical development), the annual Pediatric MedTech CEO Summit for community building, and participation in the SHIP-MD public-private partnership. The organization prioritizes healthcare impact over financial returns, leveraging Deerfield Management's healthcare investment ecosystem and philanthropic resources.

Differentiator

Problem solved

Functional benefit

Products and services

• CobiCure Fellowship for Pediatric MedTech Innovation A fellowship program launched in collaboration with all five FDA Pediatric Device Consortia and Stanford Biodesign that provides specialized training, mentorship, and educational sessions to innovators focused on pediatric care. The 2024-2025 cohort included five fellows representing the Midwest PDC, Southwest-Midwest PDC, UCSF-Stanford PDC, Alliance for Pediatric Device Innovation, and Consortium for Technology & Innovation in Pediatrics.
• Maxine and Stuart Frankel Accelerator A dedicated accelerator at CobiCure established through a $10 million grant from the Maxine and Stuart Frankel Foundation to fast-track pediatric clinical development. The accelerator focuses on novel pediatric medical devices and therapeutics through accelerated research, early-stage clinical development, robust clinical collaborations with premier children's hospitals, and streamlined development-to-market pathways for childhood cancer and rare diseases.
• Pediatric MedTech Grant Program A strategic grantmaking program providing non-dilutive funding to pediatric MedTech companies and innovators to de-risk technologies and bring them closer to clinical studies. Includes milestone-based grants such as the $2 million award to PolyVascular for developing the first-of-its-kind non-surgical heart valve for young children with congenital heart disease, progressing toward first-in-human clinical studies.
• Pediatric MedTech CEO Summit An annual forum convened by CobiCure in partnership with Stanford-based Impact-1 to bring together CEOs of leading pediatric medical device companies (35 in 2024) for peer-to-peer networking, collaboration, and problem-solving across later-stage device development and commercialization challenges specific to pediatric markets.

Quantifiable outcome

• Progressed PolyVascular's pediatric heart valve technology toward first-in-human clinical studies
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered major, core and minor.

• St. Jude Children's Research HospitalmajorStrategic or Co-development Partner · 25 February 2026Charlie Roberts, Cancer Center Director and Executive Vice President at St. Jude, participated in CobiCure's inaugural Impact Series event, sharing insights on clinical translation challenges and adaptive trial designs.
• ARPA-H Investor Catalyst HubmajorStrategic or Co-development Partner · 17 September 2024Advancium Health Network (parent of CobiCure) was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by ARPA-H. This provides access to potential funding, flexible contracting, and networking opportunities.
• FDA Pediatric Device Consortia (PDCs)coreStrategic or Co-development Partner · 10 September 2024CobiCure collaborates with all five FDA Pediatric Device Consortia for the CobiCure Fellowship for Pediatric MedTech Innovation. The five PDCs include: Midwest Pediatric Device Consortium, Southwest-Midwest National Pediatric Device Innovation Consortium, UCSF-Stanford Pediatric Device Consortium, Alliance for Pediatric Device Innovation, and Consortium for Technology & Innovation in Pediatrics.
• Stanford BiodesignmajorStrategic or Co-development Partner · 10 September 2024Stanford Biodesign provides support for the CobiCure Fellowship, with fellows learning about needs-based device innovation, device development, and commercialization of pediatric-focused technologies. Dr. Janene Fuerch serves as Assistant Director of the Stanford Biodesign Innovation Fellowship.
• PolyVascularmajorStrategic or Co-development PartnerCobiCure provided a $2M grant to PolyVascular, a company developing a first-of-its-kind non-surgical heart valve for young children with congenital heart disease. The funding helped progress their technology through milestones toward first-in-human clinical studies.
• Impact-1coreStrategic or Co-development PartnerImpact-1 is a Stanford-based pediatric and maternal health technology initiative co-directed by Dr. Janene Fuerch. CobiCure sponsors the annual Pediatric MedTech CEO Summit organized by Impact-1, and the two organizations collaborate on advancing pediatric innovation.
• FNIH (Foundation for the National Institutes of Health)majorStrategic or Co-development PartnerCobiCure is a key partner in the FNIH-led public-private partnership for pediatric medical devices (SHIP-MD), which aims to streamline, incentivize, and accelerate clinical evidence generation and product translation.
• EverPulse FoundationmajorStrategic or Co-development PartnerEverPulse is a nonprofit foundation accelerating innovation in pediatric heart care. CobiCure and EverPulse co-sponsor the PICS shark-tank pitch competition to support pediatric cardiac device innovators.
• Pediatric and Congenital Interventional Cardiology Society (PICS)minorGTM or Marketing PartnerCobiCure partners with PICS for the annual shark-tank innovation competition that provides a platform for pediatric cardiac device innovators to present their solutions.
• Alliance for Pediatric Device Innovation / JLabs Washington DCminorStrategic or Co-development PartnerCobiCure partnered with the Alliance for Pediatric Device Innovation and JLabs in Washington DC on a symposium to drive innovative solutions for pediatric cardiac and neurocritical care.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Midwest Pediatric Device Consortium: FDA-funded Pediatric Device Consortium based at Children's Hospital Los Angeles / University of Michigan, actively partnering with CobiCure's fellowship. Functions as a grant-making and accelerator for pediatric MedTech innovators in the same niche as CobiCure.
• Alliance for Pediatric Device Innovation (APDI): FDA-funded Pediatric Device Consortium operated by the Sheikh Zayed Institute at Children's National Hospital. Co-collaborates with CobiCure's fellowship and serves a similar accelerator-style role for pediatric MedTech innovators, making it a direct peer in mission and structure.
• EverPulse Foundation: Nonprofit foundation focused on accelerating pediatric heart care innovation and co-sponsor of the PICS Shark Tank with CobiCure. Directly comparable as a mission-aligned nonprofit using philanthropic capital to drive pediatric cardiovascular device innovation.
• UCSF-Stanford Pediatric Device Consortium: FDA-funded Pediatric Device Consortium at UCSF and Stanford that partners with CobiCure's fellowship program. Provides mentorship, prototyping support, and regulatory navigation to pediatric MedTech developers, directly comparable in mission and operational model.
• Advancium Health Network: CobiCure's parent nonprofit organization and direct peer, also founded by Deerfield Management and the Deerfield Foundation to advance pediatric and rare disease medical technology through grant-making and ecosystem building. Operates as a sibling mission-aligned nonprofit with overlapping leadership and shared infrastructure.
• Consortium for Technology & Innovation in Pediatrics (CTIP): One of the five FDA-funded Pediatric Device Consortia and a direct collaborator through CobiCure's Fellowship program. CTIP provides grant funding, mentorship, and regulatory support to pediatric MedTech innovators, sharing the same mission and beneficiary population as CobiCure.
• Southwest-Midwest National Pediatric Device Innovation Consortium: One of the five FDA Pediatric Device Consortia participating in CobiCure's Fellowship program. Operates as a regional pediatric MedTech accelerator with non-dilutive funding and clinical translation support, directly comparable to CobiCure's grant-making and mentorship model.

Broad incumbents

• Breakthrough T1D (formerly JDRF): Large nonprofit funding pediatric and adult type 1 diabetes research and therapeutic development. Comparable as a major nonprofit that funds pediatric medical innovation through grants and partnerships, though focused on a single disease area rather than pediatric MedTech broadly.
• Stanford Biodesign: Established needs-based medical device innovation program that partners with CobiCure's Fellowship and provides curriculum support. Functions as a broader, more mature MedTech innovation and training platform whose pediatric track overlaps with CobiCure's mission.
• Boston Children's Hospital Innovation & Digital Health Accelerator: Hospital-affiliated pediatric innovation program that supports pediatric device and digital health development. Comparable to CobiCure as a pediatric-focused innovation platform but operates as a broader incumbent leveraging a major children's hospital ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/advancium-cobicure

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CobiCure